Darren S. Cline - 12 Apr 2023 Form 4 Insider Report for IMPEL PHARMACEUTICALS INC

Role
Director
Signature
/s/ Adrian Adams as attorney-in-fact
Issuer symbol
N/A
Transactions as of
12 Apr 2023
Net transactions value
$0
Form type
4
Filing time
14 Apr 2023, 16:58:03 UTC
Previous filing
28 Mar 2023
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +20,013 $0.000000 20,013 12 Apr 2023 Common Stock 20,013 $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3rd of the total shares on April 12, 2024 and then 1/36th of the total shares vests on each monthly anniversary thereafter, with 100% of the total shares vested and exercisable on April 12, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.